Parkinsonism Provoked by Alcoholism
Ann Neurol 9:84-86, Carlen,P.L.,et al, 1981
Treatment of Advanced Parkinson Disease With Pergolide
Neurol 31:675-682, Lieberman,A.,et al, 1981
Depression, Intellectual Impairment & Parkinson Disease
Neurol 31:645-650, Mayeux,R.,et al, 1981
Progressive Supranuclear Palsy:Functional Analysis of the Response to Methysergide & Antiparkinsonian Agents
Neurol 31:1507-1518, Rafal,R.D.,et al, 1981
Extrapyramidal Side-Effects Of Metoclopramide
Lancet 2:1254-1255, Kataria,M.,et al, 1981
Parkinsonism & Tardive Dyskinesia Associated With Long-Term Metoclopramide Therapy
NEJM 305:1417, Grimes,J.D., 1981
Akinetic Mutism from Hypothalamic Damage:Successful Treatment with Dopamine Agonists
Neurol 31:1435-1439, Ross,E.D.,et al, 1981
Weekly Drug Holiday in Parkinson Disease
Neurol 31:1460-1462, Goetz,C.G.,et al, 1981
L-Dopa in Children with Progressive Neurological Disorders
Ann Neurol 7:93, Bugiani,O.,et al, 1980
Levels of y-Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders
Arch Neurol 37:352-355, Manyam,N.V.B.,et al, 1980
Presymptomatic & Early Detection in Huntington's Disease
Ann Neurol 8:343-347, Klawans,H.L.,et al, 1980
Suppression of"Rubral"Tremor with Levodopa
BMJ 281:1043, Findley,L.J.,et al, 1980
Diagnosis & Treatment, Physiologic & Pathologic Tremors
Ann Int Med 93:460-465, Jankovic,J.,et al, 1980
Intracranial Calcification in Hyperparathyroidism Associated with Gait Apraxia & Parkinsonism
Neurol 30:1005-1007, Margolin,D.,et al, 1980
Increased Ratio of Carbidopa to Levodopa in Treatment of Parkinson's Disease
Arch Neurol 37:723-726, Tourtellotte,W.W.,et al, 1980
Cigarette Smoking & Parkinson Disease:1. A Comparison of Cases with Matched Neighbors
Neurol 30:839-843, Baumann,R.J.,et al, 1980
The Occupational Therapist & the Patient with Parkinson's Disease
BMJ 280:1354-1355, Beattie,A.,et al, 1980
Parkinson Disease, Dementia, & Alzheimer Disease:Clinicopathological Correlations
Ann Neurol 7:329-335, Boller,F.,et al, 1980
Increased Dosage of Carbidopa in Patients with Parkinson's Disease Receiving Low Doses of Levodopa
Arch Neurol 37:146-149, Hoehn,M.M., 1980
Dystonic Foot Response of Parkinsonism
Arch Neurol 37:132-136, Nausieda,P.A.,et al, 1980
Levodopa & Presymptomatic Detection of Huntington's Disease-Eight-Year Follow-Up
NEJM 302:1090, Klawans,H.L.,et al, 1980
Amyloid Neuropathy & Tremor in Waldenstrom's Macroglobulinemia
Arch Neurol 37:240-242, Bajada,S.,et al, 1980
Is L-DOPA Drug Holiday Useful
Neurol 30:785-788, Direnfield,L.K.,et al, 1980
Drug Holiday & Management of Parkinson Disease
Neurol 30:1257-1261, Weiner,W.J.,et al, 1980
Neurological Disease In Ex-Far-East Prisoners Of War
Lancet 2:135-137, Gibberd,F.B.,et al, 1980
Nervous System Toxicity of Chemo Agents
Young, DF, in Vinken PJ, Bruyn GW, Handbook of Clin Neurol, North-Holland Publ Co, Amster, Vol 39, 1, 80, p 104, 1980
Dysphagia in Parkinson's Disease
Am J Gastroenterol 74:157-160, Lieberman,A.N.,et al, 1980
Exacerbation of Parkinsonism by Methyldopa
JAMA 244:2727-2728, Rosenblum,A.M.&Montgomery,E.B., 1980
Familial Fatal Parkinsonism with Alveolar Hypoventilation & Mental Depression
Ann Neurol 6:523-531, Purdy,A.,et al, 1979
Drug Holidays for Patients with Parkinsonism
JAMA 242:17-21, Clark,W.A., 1979
Lewy Bodies in the Presence of Alzheimer's Disease
Arch Neurol 36:170-171, Rosenblum,W.I.,et al, 1979
Alzheimer Neurofibrillary Tangles in Diseases Other Than Senile & Presenile Dementia
Ann Neurol 5:288-294, Wisniewski,K.,et al, 1979
Calcification of the Basal Ganglia:Computerized Tomography & Clinical Correlation
Neurol 29:328-333, Koller,W.C.,et al, 1979
Early-Morning Dystonia-A Late Side Effect of Long-Term Levodopa Therapy
Arch Neurol 36:308-310, Melamed,E., 1979
Regional Cerebral Blood Flow in Patients with Parkinson's Disease
Arch Neurol 36:344-348, Lavy,S.,et al, 1979
Oculomotor Abnormalities in Parkinson's Disease
Arch Neurol 36:360-364, Shibasaki,H.,et al, 1979
Brainstem Auditory Evoked Responses in Progressive Supranuclear Palsy
Ann Neurol 6:369, Tolosa,E.S.,et al, 1979
Progressive Supranuclear Palsy & Normal-pressure Hydrocephalus
Neurol 29:1544-1546, Morariu,M.A., 1979
Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979
Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979
The Prolactinoma Problem
NEJM 300:313-315, Reichlin,S., 1979
Bromocriptine in Parkinson Disease:Further Studies
Neurol 29:363-369, Lieberman,A.N.,et al, 1979
Parkinsonism With`On-Off'Phenomena-Intravenous Treatment With Levodopa After Major Abdominal Surgery
Arch Neurol 36:32-34, Rosin,A.J.,et al, 1979
Analysis of the Clinical Problems in Parkinsonism & the Complications of Long-term Levodopa Therapy
Neurol 29:1253-1260, Lesser,R.P.,et al, 1979
The Role of Bromocriptine in the Treatment of Parkinsonism
Neurol 29:1077-1083, Fahn,S.,et al, 1979
The Effect of Symptom Duration on Cognitive & Motor Performance in Parkinsonism
Neurol 29:951-956, Matthews,C.G.,et al, 1979
Dementia in Parkinson Disease:A Neuropathologic Study
Neurol 29:1209-1214, Hakim,A.M.,et al, 1979
Dementia in Parkinson Disease
Ann Neurol 6:355-359, Lieberman,A.,et al, 1979
L-Dopa Therapy in Parkinson's Disease:Plasma L-Dopa Concentr. Therapeutic Response, & Side Effects
Mayo Clin Proc 46:231-239, Muenter,M.D.,et al, 1979
Apomorphine Hydrochloride-Induced Improvement in Huntington's Chorea
Arch Neurol 35:27, Corsini,G.U.,et al, 1978